Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk

by
May 20, 2025
in Health Care
0
Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk.

The move is a significant shift away from the current universal recommendation, and comes just two days before the Food and Drug Administration’s independent advisers are set to vote on the formula that vaccine makers should use to potentially adjust their shots for the current strain.  

In a commentary published in the New England Journal of Medicine, Food and Drug Administration leaders wrote they will require companies to conduct lengthy clinical trials to compare the vaccine against a placebo before approving shots for healthier people. 

The shots will continue to be streamlined for people over the age of 65 and as well as children and younger adults with at least one health problem that puts them at higher risk. 

It’s not entirely clear what the news means for people under 65 who are not considered high-risk.

According to Food and Drug Administration Commissioner Marty Makary and Vinay Prasad, director of the Center for Biologics Evaluation and Research, the American “one size fits all” approach to COVID vaccination is the most aggressive compared to the rest of the world and may no longer be needed, given that people have immunity from multiple doses and likely multiple inflections.  

“The U.S. policy has sometimes been justified by arguing that the American people are not sophisticated enough to understand age- and risk-based recommendations. We reject this view,” they wrote.  

Officials said the more targeted approach still could keep annual vaccinations available for between 100 million and 200 million people. 

The new framework comes after weeks of administration officials scrutinizing the use of COVID-19 vaccines, including the delayed approval of Novavax’s shot for a much smaller population than its competitors.  

Regulators have taken a similar approach to the COVID-19 shots as they have for seasonal influenza vaccines. The FDA has approved yearly updates to COVID shots when manufacturers provide evidence they can protect against the new strain just as well as the previous year’s iteration.  

Makary and Prasad said that will be changing. 

“The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk,” Prasad and Makary wrote. 

Over the past two seasons, uptake of the annual COVID-19 booster has been poor. Makary and Prasad suggested the broad booster recommendations have also contributed to declining trust in vaccination, including the measles-mumps-rubella (MMR) vaccine.  

In the administration’s most forceful declaration to date, Makary and Prasad wrote that the MMR shot “has been clearly established as safe and highly effective.” They noted reduced MMR vaccination rates in recent years “have been a growing concern and have contributed to serious illness and deaths from measles.” 

An expert panel that advises the Centers for Disease Control and Prevention (CDC) on vaccines will vote next month on COVID vaccine recommendations.  

The panel has already indicated it would likely move to recommend a risk-based vaccination approach; boosters for people 65 and older and anyone aged 6 months and older with health conditions that puts them at high risk of severe illness. 

Previous Post

What we do and don’t know about Biden’s prostate cancer diagnosis

Next Post

The US hasn’t seen a human bird flu case in 3 months. Experts are wondering why

Next Post
The US hasn’t seen a human bird flu case in 3 months. Experts are wondering why

The US hasn’t seen a human bird flu case in 3 months. Experts are wondering why

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    How Medicaid ruling could blow up Senate GOP’s plans on Trump ‘big, beautiful bill’

    How Medicaid ruling could blow up Senate GOP’s plans on Trump ‘big, beautiful bill’

    June 26, 2025
    Reproductive rights groups fear SCOTUS ruling will inspire anti-abortion politicians 

    Reproductive rights groups fear SCOTUS ruling will inspire anti-abortion politicians 

    June 26, 2025
    Childhood vaccines were a global success story. Misinformation and other obstacles are slowing that progress, a study shows

    Childhood vaccines were a global success story. Misinformation and other obstacles are slowing that progress, a study shows

    June 26, 2025

    Trending

    New York further shields abortion pill prescribers from out-of-state prosecutions

    New York further shields abortion pill prescribers from out-of-state prosecutions

    February 3, 2025
    Harvard Chan School professor discusses delta variant

    Harvard Chan School professor discusses delta variant

    June 4, 2022
    Should colon cancer screening start at 40? 

    Should colon cancer screening start at 40? 

    July 17, 2024
    Dairy herds in Nevada test positive for newer bird flu strain that’s been linked to severe human infections

    Dairy herds in Nevada test positive for newer bird flu strain that’s been linked to severe human infections

    February 6, 2025

    Recent News

    How Medicaid ruling could blow up Senate GOP’s plans on Trump ‘big, beautiful bill’

    How Medicaid ruling could blow up Senate GOP’s plans on Trump ‘big, beautiful bill’

    June 26, 2025
    Reproductive rights groups fear SCOTUS ruling will inspire anti-abortion politicians 

    Reproductive rights groups fear SCOTUS ruling will inspire anti-abortion politicians 

    June 26, 2025

    Popular News

    • How Medicaid ruling could blow up Senate GOP’s plans on Trump ‘big, beautiful bill’
    • Reproductive rights groups fear SCOTUS ruling will inspire anti-abortion politicians 

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.